UT Southwestern Selected for Clinical Trials Network for Neurological Disorders

The University of Texas (UT) Southwestern Medical Center’s expertise in neurology has earned it a place in an innovative national clinical trials network that will make it easier to test promising treatments for patients with brain, muscle and nerve disorders.

UT Southwestern is one of 25 sites selected for the National Institute of Neurological Disorders and Stroke’s (NINDS) new Network for Excellence in Neuroscience Clinical Trials. The network, known as NeuroNEXT, represents a unique model for clinical trials for brain diseases. By creating a shared infrastructure and institutional review board, institute officials say they expect to reduce the time and expense of studies, while at the same time making new treatments available to patients more quickly. For more information, click here to read the full release.